SEC Form 4 insider trading filings tracked in real time from EDGAR

Townson Sharon — Chief Scientific Officer

Insider trading activity for Townson Sharon sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Scientific Officer
  • Company: Monte Rosa Therapeutics, Inc.
  • Total insider trades: 13
  • Total buy volume: $0
  • Total sell volume: $376K
  • Last trade: Jul 7, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Jul 6, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 6,000 N/A
Jul 6, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. SELL 400 $10K
Jul 6, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. SELL 5,600 $130K
Jul 6, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 6,000 $37K
Jun 23, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 3,000 N/A
Jun 23, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. SELL 3,000 $60K
Jun 23, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 3,000 $18K
Jun 17, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 3,000 N/A
Jun 17, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. SELL 3,000 $57K
Jun 17, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 3,000 $18K
May 29, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 6,000 N/A
May 29, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. SELL 6,000 $119K
May 29, 2026 Townson Sharon GLUE Monte Rosa Therapeutics, Inc. OTHER 6,000 $37K

← All executives · Full trades feed